Clark & Elbing LLP
Use of CFH or ApoH as a biochemical diagnostic marker for complete remission in acute myeloid leukemia
The present invention relates to a diagnostic method for acute myeloid leukemia, in particular, a method for using CFH or ApoH in patient sera as biochemical diagnostic markers to determine complete remission in acute myeloid leukemia. In accordance with this invention, CFH and ApoH are identified as a novel biochemical marker for understanding the biological mechanism and responsiveness to disease in AML patients after induction chemotherapy, and can be used as a biochemical marker for evaluating the prognosis of disease in patients after induction chemotherapy.
Industry Foundation of Chonnam National University
G G G
G01N G01N G01N
inventional additional additional
Seung Won
Lee